SEIZMET GP 1 Mg : MedlinePlus Drug Information….

SEIZMET GP 1 Mg

Glimepiride (1mg), Metformin SR (500mg), Pioglitazone (15mg)

SEIZMET GP 1 combines Glimepiride, Metformin SR (Sustained Release), and Pioglitazone, offering a comprehensive treatment approach for managing type 2 diabetes. This medication is designed to improve blood sugar control through multiple mechanisms, thereby reducing the risks associated with diabetes, including heart disease, kidney damage, and nerve complications. This guide provides in-depth information on the uses, recommended dosage, pricing, potential side effects, and composition of SEIZMET GP 1.

Uses

SEIZMET GP 1 is primarily used for:

• Effective Blood Sugar Management: Aims to lower glucose levels in patients with type 2 diabetes, improving overall diabetes control.
• Reduction of Diabetes-Related Complications: Helps prevent the long-term complications of diabetes, such as cardiovascular diseases, by maintaining effective blood sugar levels.

Dosage

• Standard Dosage: The typical dosage of SEIZMET GP 1 is one tablet taken orally, once daily, with the first main meal of the day. This helps to reduce the gastrointestinal side effects associated with Metformin and the risk of hypoglycemia associated with Glimepiride.
• Method of Administration: The tablet should be swallowed whole, not crushed or chewed, to maintain the integrity of the sustained-release formulation of Metformin.
• Dosage Adjustments: Depending on the patient's blood glucose response and tolerability, the dosage may need to be adjusted under the guidance of a healthcare provider.

Price

The cost of SEIZMET GP 1 varies based on various factors, including location, pharmacy, and whether the patient's health insurance plan covers the medication. It is generally priced competitively to be accessible for patients requiring ongoing diabetes management.

Side Effects

While SEIZMET GP 1 is effective for many patients, some may experience side effects, including:

• Common Side Effects: Hypoglycemia (especially from Glimepiride), gastrointestinal issues (mostly from Metformin), and weight gain (associated with Pioglitazone).
• Serious Side Effects: Lactic acidosis (a rare but potentially fatal condition linked to Metformin), significant fluid retention, and heart failure (related to Pioglitazone). It's also important to monitor for signs of liver disease or bladder cancer, which although rare, have been associated with Pioglitazone.
• Alerts and Precautions: Patients with a history of heart failure or bladder cancer should discuss the use of Pioglitazone with their healthcare provider.

Composition

Each tablet of SEIZMET GP 1 contains:

• Active Ingredients: Glimepiride (1mg), Metformin SR (500mg), and Pioglitazone (15mg).
• Inactive Ingredients: Common excipients may include cellulose, polyethylene glycol, povidone, and magnesium stearate, which help in tablet formulation and sustained release of the active ingredients.

Conclusion

SEIZMET GP 1 is an integral part of diabetes management for individuals with type 2 diabetes, offering a multi-faceted approach to control high blood sugar effectively. By combining three different medications, it targets various pathways involved in glucose metabolism, providing substantial benefits in reducing the risk of diabetes-related complications. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. Gynecology, Pediatrics, Dental care, and Dermatology. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

  EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 BUY NOW